Big Gain For KTRA

KTRA (KTRA:NASDAQ) rocketted at $1.02, a gain of 20%. The stock got featured on our News Catalysts scanner on Mon, Oct 11, 2021 at 09:39 AM in the 'MISCELLANEOUS' category. From Mon, Oct 04, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Oct 13, 2021 at $1.08 with a volume of 9M+.
About KTRA (KTRA:NASDAQ)
DelMar Pharmaceuticals Inc is a clinical and commercial-stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. The company's principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. It also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. All the business activity of the firm is functioned through the region of Canada.
Top 10 Gainers:
- Hexindai Inc. (HX:NASDAQ), 42.58%
- HUDI (HUDI:NASDAQ), 26.03%
- GRVI (GRVI:NASDAQ), 23.83%
- Fuel Tech, Inc. (FTEK:NASDAQ), 22.11%
- Camber Energy, Inc. (CEI:NYSEMKT), 21.58%
- DNA (DNA:NYSE), 20.21%
- KTRA (KTRA:NASDAQ), 20.01%
- BON (BON:NASDAQ), 17.06%
- Yunji Inc. (YJ:NASDAQ), 15.84%
- Tilray, Inc. (TLRY:NASDAQ), 15.79%